LCK and breast cancer: Immunohistochemical analysis of mammary tumors indicated that nuclear SphK1 can co-localize with Erk1/2, Lck/Yes novel tyrosine kinase (LYN), V-akt murine thymoma viral oncogene homolog (AKT), or Nuclear Factor κB (NF-κB).